APA

Ploussard G., Xylinas E., Durand X., Ouzaïd I., Allory Y., Bouanane M., Abbou C., Salomon L. & de la Taille A. (20111013). Magnetic resonance imaging does not improve the prediction of misclassification of prostate cancer patients eligible for active surveillance when the most stringent selection criteria are based on the saturation biopsy scheme. : BJU international.

Chicago

Ploussard Guillaume, Xylinas Evanguelos, Durand Xavier, Ouzaïd Idir, Allory Yves, Bouanane Mohamed, Abbou Claude-Clément, Salomon Laurent and de la Taille Alexandre. 20111013. Magnetic resonance imaging does not improve the prediction of misclassification of prostate cancer patients eligible for active surveillance when the most stringent selection criteria are based on the saturation biopsy scheme. : BJU international.

Harvard

Ploussard G., Xylinas E., Durand X., Ouzaïd I., Allory Y., Bouanane M., Abbou C., Salomon L. and de la Taille A. (20111013). Magnetic resonance imaging does not improve the prediction of misclassification of prostate cancer patients eligible for active surveillance when the most stringent selection criteria are based on the saturation biopsy scheme. : BJU international.

MLA

Ploussard Guillaume, Xylinas Evanguelos, Durand Xavier, Ouzaïd Idir, Allory Yves, Bouanane Mohamed, Abbou Claude-Clément, Salomon Laurent and de la Taille Alexandre. Magnetic resonance imaging does not improve the prediction of misclassification of prostate cancer patients eligible for active surveillance when the most stringent selection criteria are based on the saturation biopsy scheme. : BJU international. 20111013.